Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
Dabur's consolidated revenue is expected to register mid to high single digit growth during Q1 FY25
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
_256_384.jpg)
Glenmark released Picture Post Cards on World Vitiligo Day
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
This tie-up will have no impact on any other brands of the company
Subscribe To Our Newsletter & Stay Updated
